Aster Capital Management’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
Other funds holding PAHC
Aster Capital Management's PAHC Position: Q2 2026 in Review
Aster Capital Management reduced its Phibro Animal Health (PAHC) stake by 10% in Q2 2026, selling an estimated $675 and leaving 144 shares worth $4.52K. The position accounts for ﹤0.01% of the portfolio, ranked #733.
Aster Capital Management first reported a position in PAHC in Q4 2024 and has held it in 4 quarters since. The position peaked at $4.93K in Q2 2025. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.
- Aster Capital Management held 144 shares of Phibro Animal Health worth $4.52K as of Q2 2026.
- Aster Capital Management sold 16 Phibro Animal Health shares in Q2 2026, an estimated $675.
- Phibro Animal Health made up ﹤0.01% of Aster Capital Management's portfolio in Q2 2026, its #733 holding.
- Aster Capital Management first reported a position in Phibro Animal Health in Q4 2024 and has held it in 4 quarters since.
- Aster Capital Management's Phibro Animal Health position peaked at $4.93K in Q2 2025.
- 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.
Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.